158 related articles for article (PubMed ID: 33004271)
1. Upfront surgery or definitive radiotherapy for patients with p16-negative oropharyngeal squamous cell carcinoma. A GETTEC multicentric study.
Culié D; Viotti J; Modesto A; Schiappa R; Chamorey E; Dassonville O; Poissonnet G; Guelfucci B; Bizeau A; Vergez S; Dupret-Bories A; Garrel R; Fakhry N; Santini L; Lallemant B; Chambon G; Sudaka A; Peyrade F; Saada-Bouzid E; Benezery K; Jourdan-Soulier F; Chapel F; Ramay AS; Roger P; Galissier T; Coste V; Ben Lakdar A; Guerlain J; Temam S; Mirghani H; Gorphe P; Bozec A
Eur J Surg Oncol; 2021 Feb; 47(2):367-374. PubMed ID: 33004271
[TBL] [Abstract][Full Text] [Related]
2. Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric study.
Culié D; Schiappa R; Modesto A; Viotti J; Chamorey E; Dassonville O; Poissonnet G; Bizeau A; Vergez S; Dupret-Bories A; Fakhry N; Santini L; Lallemant B; Chambon G; Sudaka A; Peyrade F; Saada-Bouzid E; Benezery K; Jourdan-Soulier F; Chapel F; Ramay AS; Roger P; Galissier T; Coste V; Ben Lakdar A; Guerlain J; Mirghani H; Gorphe P; Guelfucci B; Garrel R; Temam S; Bozec A
Eur J Surg Oncol; 2021 Jun; 47(6):1389-1397. PubMed ID: 33390333
[TBL] [Abstract][Full Text] [Related]
3. Impact of HPV-associated p16-expression and other clinical factors on therapeutic decision-making in patients with oropharyngeal cancer: A GETTEC multicentric study.
Culié D; Garrel R; Viotti J; Schiappa R; Chamorey E; Fakhry N; Lallemant B; Vergez S; Dupret-Bories A; Dassonville O; Poissonnet G; Santini J; Peyrade F; Benezery K; Sudaka A; Jourdan-Soulier F; Chapel F; Guelfucci B; Bozec A
Eur J Surg Oncol; 2018 Dec; 44(12):1908-1913. PubMed ID: 29871820
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
5. Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric study.
Milliet F; Bozec A; Schiappa R; Viotti J; Modesto A; Dassonville O; Poissonnet G; Guelfucci B; Bizeau A; Vergez S; Dupret-Bories A; Garrel R; Fakhry N; Santini L; Lallemant B; Chambon G; Sudaka A; Peyrade F; Saada-Bouzid E; Benezery K; Jourdan-Soulier F; Chapel F; Sophie Ramay A; Roger P; Galissier T; Coste V; Ben Lakdar A; Guerlain J; Temam S; Mirghani H; Gorphe P; Chamorey E; Culié D
Oral Oncol; 2021 Jan; 112():105041. PubMed ID: 33129057
[TBL] [Abstract][Full Text] [Related]
6. Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
Zenga J; Wilson M; Adkins DR; Gay HA; Haughey BH; Kallogjeri D; Michel LS; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1118-27. PubMed ID: 25902372
[TBL] [Abstract][Full Text] [Related]
7. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
8. The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.
Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):253-259. PubMed ID: 27918781
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Survival Outcomes Among Human Papillomavirus-Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational Study.
Kelly JR; Park HS; An Y; Contessa JN; Yarbrough WG; Burtness BA; Decker R; Husain Z
JAMA Oncol; 2017 Aug; 3(8):1107-1111. PubMed ID: 28056116
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
[TBL] [Abstract][Full Text] [Related]
11. Survival analysis of 287 oropharyngeal squamous cell carcinoma patients in a single institution: a retrospective comparison of two consecutive time intervals with surgical and conservative treatment approaches.
Münscher A; Bussmann L; Sehner S; Knaack S; Gliese A; Tribius S; Clauditz T; Lörincz BB
Eur Arch Otorhinolaryngol; 2017 Aug; 274(8):3211-3219. PubMed ID: 28555274
[TBL] [Abstract][Full Text] [Related]
12. Commercial Claims-Based Comparison of Survival and Toxic Effects of Definitive Radiotherapy vs Primary Surgery in Patients With Oropharyngeal Squamous Cell Carcinoma.
Sher DJ; Agiro A; Zhou S; Day AT; DeVries A
JAMA Otolaryngol Head Neck Surg; 2018 Oct; 144(10):913-922. PubMed ID: 30326060
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
14. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
[TBL] [Abstract][Full Text] [Related]
15. Enhancing regional control in p16-negative oropharyngeal cancer: A propensity score-matched analysis of upfront neck dissection and definitive chemoradiotherapy.
Lee TL; Fang WC; Lee IC; Lirng JF; Chang CF; Hsu YB; Chu PY; Wang YF; Yang MH; Chang PM; Wang LW; Tai SK
J Chin Med Assoc; 2024 May; 87(5):516-524. PubMed ID: 38501795
[TBL] [Abstract][Full Text] [Related]
16. Association of Extracapsular Spread With Survival According to Human Papillomavirus Status in Oropharynx Squamous Cell Carcinoma and Carcinoma of Unknown Primary Site.
Kharytaniuk N; Molony P; Boyle S; O'Leary G; Werner R; Heffron C; Feeley L; Sheahan P
JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):683-690. PubMed ID: 27196434
[TBL] [Abstract][Full Text] [Related]
17. Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan.
Saito Y; Hayashi R; Iida Y; Mizumachi T; Fujii T; Matsumoto F; Beppu T; Yoshida M; Shinomiya H; Kamiyama R; Kitano M; Yokoshima K; Fujimoto Y; Hama T; Yamashita T; Okami K; Miura K; Fujisawa T; Sano D; Kato H; Minami S; Sugasawa M; Masuda M; Ota I; Iwae S; Kawata R; Monden N; Imai T; Asakage T; Okada M; Yoshikawa T; Tanioka K; Kitayama M; Doi M; Fujii S; Fujii M; Oridate N; Nakamizo M; Yoshimoto S; Homma A; Nibu KI; Yane K
Cancer; 2020 Sep; 126(18):4177-4187. PubMed ID: 32648953
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
19. Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric study.
Milliet F; Bozec A; Schiappa R; Viotti J; Modesto A; Dassonville O; Poissonnet G; Guelfucci B; Bizeau A; Vergez S; Dupret-Bories A; Garrel R; Fakhry N; Santini L; Lallemant B; Chambon G; Sudaka A; Peyrade F; Saada-Bouzid E; Benezery K; Jourdan-Soulier F; Chapel F; Sophie Ramay A; Roger P; Galissier T; Coste V; Ben Lakdar A; Guerlain J; Temam S; Mirghani H; Gorphe P; Chamorey E; Culié D
Oral Oncol; 2021 Nov; 122():105503. PubMed ID: 34500315
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival and swallowing outcomes in advanced stage oropharyngeal squamous cell carcinomas.
Clark JM; Holmes EM; O'Connell DA; Harris J; Seikaly H; Biron VL
Papillomavirus Res; 2019 Jun; 7():1-10. PubMed ID: 30267774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
